MAXWELL FINLAND, M.D., F.A.C.P.; FRANCIS C. LOWELL, M.D.; WILLIAM C. SPRING JR., M.D.; F. H. LASKEY TAYLOR, Ph.D.
Marshall and Long1 have recently reported observations on the intravenous use of the sodium salt of sulfapyridine2 in patients in whom it is desirable to attain high concentrations of sulfapyridine in the blood rapidly and in patients in whom oral therapy results in inadequate concentrations or entails undue discomfort. Since occasions similar to the ones they outlined frequently arise, and since under such conditions the procedure may be of life-saving value, further reports of the use of this compound seem justified. While the clinical findings reported in this paper with respect to sodium sulfapyridine are largely confirmatory, additional data are
FINLAND M, LOWELL FC, SPRING WC, TAYLOR FHL. PARENTERAL SULFAPYRIDINE; THE INTRAVENOUS USE OF SODIUM SULFAPYRIDINE AND A REPORT OF CLINICAL AND LABORATORY OBSERVATIONS ON THE USE OF A GLUCOSE-SULFAPYRIDINE SOLUTION(PARENTERAL SULFAPYRIDINE; THE INTRAVENOUS USE OF SODIUM SULFAPYRIDINE AND A REPORT OF CLINICAL AND LABORATORY OBSERVATIONS ON THE USE OF A GLUCOSE-SULFAPYRIDINE SOLUTION*). Ann Intern Med. 1940;13:1105–1120. doi: 10.7326/0003-4819-13-7-1105
Download citation file:
Published: Ann Intern Med. 1940;13(7):1105-1120.
Education and Training.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use